Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

L Y Chan

Showing results (351-360 of 371) with videos related to

Pageof 38
Sort By:
The Lancet. Gastroenterology & Hepatology|April 14, 2017
Tenofovir alafenamide versus tenofovir disoproxil fumarate for the treatment of HBeAg-positive chronic hepatitis B virus infection: a randomised, double-blind, phase 3, non-inferiority trialHenry L Y Chan, Scott Fung, Wai Kay Seto, et al.
Cancer Discovery|March 1, 2020
Plasma DNA End-Motif Profiling as a Fragmentomic Marker in Cancer, Pregnancy, and TransplantationPeiyong Jiang, Kun Sun, Wenlei Peng, et al.
Cancer Research|October 27, 2012
Host immune defense peptide LL-37 activates caspase-independent apoptosis and suppresses colon cancerShun X Ren, Alfred S L Cheng, Ka F To, et al.
The New England Journal of Medicine|January 22, 2005
Clopidogrel versus aspirin and esomeprazole to prevent recurrent ulcer bleedingFrancis K L Chan, Jessica Y L Ching, Lawrence C T Hung, et al.
Cancer Research|December 16, 2014
Epigenetic silencing of miR-490-3p reactivates the chromatin remodeler SMARCD1 to promote Helicobacter pylori-induced gastric carcinogenesisJing Shen, Zhangang Xiao, William K K Wu, et al.
Gastroenterology|November 11, 2021
Off-Therapy Response After Nucleos(t)ide Analogue Withdrawal in Patients With Chronic Hepatitis B: An International, Multicenter, Multiethnic Cohort (RETRACT-B Study)Grishma Hirode, Hannah S J Choi, Chien-Hung Chen, et al.
The American Journal of Gastroenterology|January 31, 2023
Incidence of Hepatic Decompensation After Nucleos(t)ide Analog Withdrawal: Results From a Large, International, Multiethnic Cohort of Patients With Chronic Hepatitis B (RETRACT-B Study)Grishma Hirode, Bettina E Hansen, Chien-Hung Chen, et al.
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association|July 21, 2022
Differential Relapse Patterns After Discontinuation of Entecavir vs Tenofovir Disoproxil Fumarate in Chronic Hepatitis BHannah S J Choi, Grishma Hirode, Chien-Hung Chen, et al.
The American Journal of Gastroenterology|March 14, 2024
Limited Sustained Remission After Nucleos(t)ide Analog Withdrawal: Results From a Large, Global, Multiethnic Cohort of Patients With Chronic Hepatitis B (RETRACT-B Study)Grishma Hirode, Bettina E Hansen, Chien-Hung Chen, et al.
Gastroenterology|October 11, 2015
Combination of Tenofovir Disoproxil Fumarate and Peginterferon α-2a Increases Loss of Hepatitis B Surface Antigen in Patients With Chronic Hepatitis BPatrick Marcellin, Sang Hoon Ahn, Xiaoli Ma, et al.
Pageof 38

Showing results (351-360 of 371) with videos related to

Sort By:
Pageof 38
The Lancet. Gastroenterology & Hepatology|April 14, 2017
Tenofovir alafenamide versus tenofovir disoproxil fumarate for the treatment of HBeAg-positive chronic hepatitis B virus infection: a randomised, double-blind, phase 3, non-inferiority trialHenry L Y Chan, Scott Fung, Wai Kay Seto, et al.
Cancer Discovery|March 1, 2020
Plasma DNA End-Motif Profiling as a Fragmentomic Marker in Cancer, Pregnancy, and TransplantationPeiyong Jiang, Kun Sun, Wenlei Peng, et al.
Cancer Research|October 27, 2012
Host immune defense peptide LL-37 activates caspase-independent apoptosis and suppresses colon cancerShun X Ren, Alfred S L Cheng, Ka F To, et al.
The New England Journal of Medicine|January 22, 2005
Clopidogrel versus aspirin and esomeprazole to prevent recurrent ulcer bleedingFrancis K L Chan, Jessica Y L Ching, Lawrence C T Hung, et al.
Cancer Research|December 16, 2014
Epigenetic silencing of miR-490-3p reactivates the chromatin remodeler SMARCD1 to promote Helicobacter pylori-induced gastric carcinogenesisJing Shen, Zhangang Xiao, William K K Wu, et al.
Gastroenterology|November 11, 2021
Off-Therapy Response After Nucleos(t)ide Analogue Withdrawal in Patients With Chronic Hepatitis B: An International, Multicenter, Multiethnic Cohort (RETRACT-B Study)Grishma Hirode, Hannah S J Choi, Chien-Hung Chen, et al.
The American Journal of Gastroenterology|January 31, 2023
Incidence of Hepatic Decompensation After Nucleos(t)ide Analog Withdrawal: Results From a Large, International, Multiethnic Cohort of Patients With Chronic Hepatitis B (RETRACT-B Study)Grishma Hirode, Bettina E Hansen, Chien-Hung Chen, et al.
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association|July 21, 2022
Differential Relapse Patterns After Discontinuation of Entecavir vs Tenofovir Disoproxil Fumarate in Chronic Hepatitis BHannah S J Choi, Grishma Hirode, Chien-Hung Chen, et al.
The American Journal of Gastroenterology|March 14, 2024
Limited Sustained Remission After Nucleos(t)ide Analog Withdrawal: Results From a Large, Global, Multiethnic Cohort of Patients With Chronic Hepatitis B (RETRACT-B Study)Grishma Hirode, Bettina E Hansen, Chien-Hung Chen, et al.
Gastroenterology|October 11, 2015
Combination of Tenofovir Disoproxil Fumarate and Peginterferon α-2a Increases Loss of Hepatitis B Surface Antigen in Patients With Chronic Hepatitis BPatrick Marcellin, Sang Hoon Ahn, Xiaoli Ma, et al.
Pageof 38